Cargando…

Outcomes of Kidney Transplantation with a CMV Matching Allocation Schema

BACKGROUND: Cytomegalovirus (CMV) infection continues to be a major cause of morbidity in kidney transplant recipients. The CMV donor-positive (D+)/recipient-negative (R−) serostatus pairing poses highest risk for CMV disease. METHODS: In September 2012, we adopted a CMV matching allocation policy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strasfeld, Lynne, Basuli, Debargha, Norman, Douglas, Langewisch, Eric, Olyaei, Ali, Lockridge, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631860/ http://dx.doi.org/10.1093/ofid/ofx162.028

Ejemplares similares

Use of a Sulfa Desensitization Protocol in Solid Organ Transplant Recipients
por: Kirsch, Denise, et al.
Publicado: (2017)

A rare case of AIDS co-infected with COVID-19 presenting with disseminated Herpes Zoster complicated with CMV and Varicella Zoster virus Meningoencephalitis
por: Daodu, Joseph, et al.
Publicado: (2022)

Beyond Human Limits: Harnessing Artificial Intelligence to Optimize Immunosuppression in Kidney Transplantation
por: Basuli, Debargha, et al.
Publicado: (2023)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Incidental detection of operational tolerance in a deceased donor kidney transplant recipient lost to follow-up for more than 10 years: A case report and literature review
por: Roy, Sasmit, et al.
Publicado: (2023)

Impact of CMV Blips in Transplant Recipients
por: Lodding, Isabelle Paula, et al.
Publicado: (2017)

Elevated Anion Gap Metabolic Acidosis With High Osmolar Gap and Increased Serum Acetone Level: A Case Report
por: Basuli, Debargha, et al.
Publicado: (2022)

638. CMV-Specific T-Cell Immune Responses in Older vs. Younger Kidney Transplant Recipients
por: Liang, Emily, et al.
Publicado: (2018)

944. CMV Peak Viral Load, Recurrence, Duration, and Outcomes in Kidney Transplant Recipients
por: Avery, Robin K, et al.
Publicado: (2021)

1747. Impact of Inappropriately Low Cytomegalovirus (CMV) Prophylaxis Dosing on CMV Outcomes Among Lung Transplant (LT) Recipients
por: Watts, Corey, et al.
Publicado: (2019)

2702. A Case Series of Kidney Transplant Recipients on Belatacept with CMV Infection in a Single Academic Center
por: Feller, Fionna, et al.
Publicado: (2023)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1590. A Hybrid CMV Prevention Strategy Is Effective in Preventing CMV Disease Outcomes in Pediatric Solid Organ Transplant Patients
por: Ore, Lucia Dalle, et al.
Publicado: (2018)

COVID-19 and HSCT (Hematopoietic stem cell transplant)
por: Strasfeld, Lynne
Publicado: (2022)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

2696. Impact of an Ultrasensitive Cytomegalovirus (CMV) Quantitative Nucleic Acid Test (qNAT) on CMV Detection and Therapy in Renal Transplant Recipients
por: Beechar, Vivek, et al.
Publicado: (2023)

1566. Is Primary CMV Infection Post-transplant Influenced by Circadian Rhythms?
por: Rafferty, Hannah, et al.
Publicado: (2018)

Towards a Rational Balanced Pancreatic and Islet Allocation Schema
por: Kandeel, Fouad, et al.
Publicado: (2021)

1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
por: Roumpz, Caroline G, et al.
Publicado: (2021)

491. Characterizing the Association of Pre-Existing Cytomegalovirus (CMV)-specific Humoral Immunity with CMV Reactivation Risk after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2022)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

2697. The Impact of Universal Deceased Donor Screening on Donor-Derived Toxoplasmosis in Solid-Organ Transplant: Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
por: Strasfeld, Lynne, et al.
Publicado: (2019)

1538. High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
por: Batista, Marjorie, et al.
Publicado: (2018)

1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
por: Sharova, Anna, et al.
Publicado: (2019)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

The role of the pharmacist in the management of kidney transplant recipients
por: Wiegel, Joshua J., et al.
Publicado: (2016)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
por: Fontana, Lauren, et al.
Publicado: (2019)

1896. A Retrospective Cohort Analysis to Determine the Incidence of CMV Viremia and Progression to CMV Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation at an Academic Children’s Hospital
por: Hayes, Molly, et al.
Publicado: (2018)

Association between appearance schemas and personality traits
por: Maia, B., et al.
Publicado: (2021)

Suppression of CMV Infection with Letermovir in a Kidney Transplant Patient
por: Koepf, Uta S, et al.
Publicado: (2020)

Thrombosis Associated With Cytomegalovirus (CMV) in a Kidney Transplant Recipient
por: Wang, Lin, et al.
Publicado: (2021)

1551. The Impact of Recurrent CMV Disease on Long-Term Survival in Solid Organ Transplant Recipients
por: Gardiner, Bradley, et al.
Publicado: (2018)

Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant
por: Kim, Taeeun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1m5qagt7upkutea03dnfq41ku